ATAI — AtaiBeckley Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-06-18.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ATAI
| date | signal | measured base rate |
|---|---|---|
| 2026-08-20 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-08-19 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
| 2026-08-07 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-07-17 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-07-16 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-06-29 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-07 | HERSHBERG ROBERT Director | Open-market sale 10b5-1 plan | 100.0K | 4.96 | 496.0K |
| 2026-07-07 | HERSHBERG ROBERT Director | Option exercise 10b5-1 plan | 51.1K | 1.35 | 69.0K |
| 2026-07-07 | HERSHBERG ROBERT Director | Option exercise 10b5-1 plan | 48.9K | 1.35 | 66.0K |
| 2026-06-26 | Kochendoerfer Gerd Chief Operating Officer | Open-market sale 10b5-1 plan | 50.0K | 5.00 | 250.0K |
| 2026-06-26 | Kochendoerfer Gerd Chief Operating Officer | Option exercise 10b5-1 plan | 50.0K | 1.60 | 80.0K |
| 2026-06-25 | Craig Kevin James Chief Medical Officer | Open-market sale 10b5-1 plan | 42.6K | 4.51 | 192.0K |
| 2026-06-25 | Craig Kevin James Chief Medical Officer | Option exercise 10b5-1 plan | 33.1K | 1.50 | 49.6K |
| 2026-06-25 | Craig Kevin James Chief Medical Officer | Option exercise 10b5-1 plan | 9.5K | 1.18 | 11.2K |
| 2026-04-20 | Craig Kevin James Chief Medical Officer | Open-market sale 10b5-1 plan | 42.6K | 5.00 | 212.9K |
| 2026-04-20 | Craig Kevin James Chief Medical Officer | Option exercise 10b5-1 plan | 27.3K | 1.50 | 40.9K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Deep Track Capital, LP | 42.5M | 12.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | 41.6M | 11.8M |
| UBS Group AG | 26.3M | 7.4M |
| BlackRock, Inc. | 24.2M | 6.8M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 20.0M | 5.6M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 18.7M | 5.3M |
| MILLENNIUM MANAGEMENT LLC | 15.4M | 4.4M |
| MORGAN STANLEY | 13.6M | 3.9M |
| Candriam S.C.A. | 10.9M | 3.1M |
| Qube Research & Technologies Ltd | 10.2M | 2.9M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Jim Cramer Calls This Industrial Stock ‘Sensational’ And Ameriprise Financial ‘Fantastic’ · 2026-08-07 · benzinga
Ask the AI about ATAI
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →